Related Experiment Videos
Concurrent Langerhans cell histiocytosis and myelodysplasia in children
G Surico1, P Muggeo, N Rigillo
1Department of Pediatric Hematology and Oncology, II Pediatric Clinic, University of Bari, Bari, Italy. n.rigillo@pediatria2.uniba.it
Background:
Langerhans cell histiocytosis (LCH) is characterized by the proliferation of abnormal histiocytes (Langerhans cells), whose origin as a reactive process or a neoplastic disorder is still poorly understood. Although LCH has been recorded as being associated with malignant neoplasms, concurrence of LCH and myelodysplastic syndrome has not been reported so far.
Procedure:
We report on four children aged 23, 25, 26, and 53 months with multisystem LCH with organ dysfunction (bone marrow and liver) whose bone marrow pictures, taken at diagnosis, revealed the presence of myelodysplastic abnormalities (RA, RAEB, RAEB-t).
Results:
We suggest that the commonly used expression of "organ dysfunction," which refers to clinical and functional alterations, could be explained by a myelodysplastic-like disorder.
Conclusions:
The contemporary presence of both events may provide a better understanding of the pathogenesis of LCH, especially in young children with multisystem disease and organ dysfunction, who are known to have a very poor outcome.